| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/31/2013 | CN103223050A Traditional Chinese medicine extract and preparation method thereof |
| 07/31/2013 | CN103223049A Chinese medicinal extract |
| 07/31/2013 | CN103223045A Chinese medicinal composition |
| 07/31/2013 | CN103223044A Traditional Chinese medicinal composition and its preparation method |
| 07/31/2013 | CN103223043A 中药组合物 Chinese medicine composition |
| 07/31/2013 | CN103223042A 中药组合物 Chinese medicine composition |
| 07/31/2013 | CN103223041A 中药组合物 Chinese medicine composition |
| 07/31/2013 | CN103223040A 中药组合物 Chinese medicine composition |
| 07/31/2013 | CN103223036A Traditional Chinese medicinal composition |
| 07/31/2013 | CN103223030A Chinese medicinal composition |
| 07/31/2013 | CN103223029A Traditional Chinese medicinal composition and its preparation method |
| 07/31/2013 | CN103223028A Extract product of traditional Chinese medicine |
| 07/31/2013 | CN103223023A T-cell lymphoma treatment combination drug |
| 07/31/2013 | CN103223018A Osmanthus fragrans polyphenol extract product, and preparation method and uses thereof |
| 07/31/2013 | CN103223014A Traditional Chinese medicinal composition and its preparation method |
| 07/31/2013 | CN103223013A Traditional Chinese medicinal composition and its preparation method |
| 07/31/2013 | CN103223011A Extract product of traditional Chinese medicine |
| 07/31/2013 | CN103223004A Chinese medicinal composition |
| 07/31/2013 | CN103223003A 中药组合物 Chinese medicine composition |
| 07/31/2013 | CN103223002A Extract product of traditional Chinese medicine |
| 07/31/2013 | CN103222998A Comprehensive extracting method for platycodin and polysaccharide |
| 07/31/2013 | CN103222993A Chinese medicinal extract |
| 07/31/2013 | CN103222986A Application of gingerol and ruddle composition in preparation of attenuated synergistic medicaments in cancer chemotherapy |
| 07/31/2013 | CN103222970A Application of asymmetric single-carbonyl curcumin analogues in preparing antitumor medicines |
| 07/31/2013 | CN103222965A Imatinib mesylate tablet and preparation method thereof |
| 07/31/2013 | CN103222961A Injection Cu(DDC)2 protein nano-particle preparation used for treating tumor, and preparation method thereof |
| 07/31/2013 | CN103222959A Interleukin-2 long-acting slow-release microsphere, preparation method and application thereof |
| 07/31/2013 | CN102746307B 1-N-benzyl allopurinol derivative as well as preparation method and application thereof |
| 07/31/2013 | CN102703489B Construction method for prokaryotic secretory expression vector of protein transduction domain-Apoptin (PTD-Apoptin) fusion protein and application of prokaryotic secretory expression vector |
| 07/31/2013 | CN102697719B Oily drug composition containing vitamin K1 |
| 07/31/2013 | CN102688191B Medicine composition containing vitamin K1 and oil |
| 07/31/2013 | CN102657840B Stasis-removing and inflammation-diminishing traditional Chinese medicine composition, stasis-removing and inflammation-diminishing pills, stasis-removing and inflammation-diminishing plaster and preparation method thereof |
| 07/31/2013 | CN102631624B Chinese herba external lotion for treating swelling of upper limb of affected side after breast cancer surgery |
| 07/31/2013 | CN102631464B Chinese medicinal ointment for treating infantile hemangioma and preparation method thereof |
| 07/31/2013 | CN102600181B Application of (4-substituted benzoyl) fluorobenzene salicylamide compound in preparing anti-leukemie medicament |
| 07/31/2013 | CN102558360B Trypsin inhibitor and preparation method and application thereof |
| 07/31/2013 | CN102552848B Ginger and kudzuvine root composition for reducing vomiting caused by cancer chemotherapy and improving chemotherapy effects, and preparation method for ginger and kudzuvine root composition |
| 07/31/2013 | CN102526498B Chinese medicine for eliminating toxic and side effects after nasopharyngeal carcinoma radiotherapy and preparation method and administration way thereof |
| 07/31/2013 | CN102370886B Traditional Chinese medicinal composition for resisting breast cancer metastasis |
| 07/31/2013 | CN102349871B Nano-micro drug delivery system and preparation method of 10-hydroxyl camptothecin |
| 07/31/2013 | CN102321178B Novel gonadotropin releasing hormone oriented fusion protein mutant |
| 07/31/2013 | CN102239838B Terpenoid as well as preparation method and application thereof |
| 07/31/2013 | CN102219705B Crystallization process of columnar crystal of L-serine and application of columnar crystal |
| 07/31/2013 | CN102210663B Diarylalkanes as potent inhibitors of binuclear enzymes |
| 07/31/2013 | CN102210646B Human rabies vaccine gel and preparation method thereof |
| 07/31/2013 | CN102078602B Antitumor composite and preparation method thereof |
| 07/31/2013 | CN101959887B Pyrrolopyridines as kinase inhibitors |
| 07/31/2013 | CN101906006B Method for efficiently synthesizing cis-stilbene derivative and phosphate disodium salt predrug thereof |
| 07/31/2013 | CN101903034B Method for increasing the therapeutic efficacy of curcuminoids and analogues |
| 07/31/2013 | CN101875508B Preparation method of Fe3O4 nano-magnetic powder lymphatic tracer and application thereof |
| 07/31/2013 | CN101863883B Piperidone azine compound with activity of resisting leukemia K562 cell proliferation and preparation method thereof |
| 07/31/2013 | CN101787066B Cytarabine derivatives and purposes thereof in resisting cancers and tumors |
| 07/31/2013 | CN101716163B Letrozole targeted slow-release transdermal patch and preparation method thereof |
| 07/31/2013 | CN101715451B Novel pyridopyrazine derivatives, process of manufacturing and uses thereof |
| 07/31/2013 | CN101668853B Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them |
| 07/31/2013 | CN101663045B A composition containing arazyme for the prevention and treatment of cancer |
| 07/31/2013 | CN101602653B Halogenated hydroxyl aromatic methane compounds, preparation method and use thereof |
| 07/31/2013 | CN101537189B Aptamer and new use of derivative thereof |
| 07/31/2013 | CN101528749B Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 07/31/2013 | CN101460462B Spirocyclic nitriles as protease inhibitors |
| 07/31/2013 | CN101443017B Medication against breast cancer and related diseases |
| 07/31/2013 | CN101412742B Nitric acid ester medicament for inhibiting angiogenesis |
| 07/31/2013 | CN101404995B Lignane compound-containing oil-in-water emulsion and composition comprising the same |
| 07/31/2013 | CN101379192B Anti-Met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products |
| 07/31/2013 | CN101375863B Method for extracting polysaccharide and other multiple active components in boiling juice of trepang |
| 07/31/2013 | CN101294187B Method for sustained-releasing polypeptide with biological activity and application thereof |
| 07/31/2013 | CN101117635B Fusion expression of PTD,HIF ODD and tumour inhibitory gene and uses thereof |
| 07/31/2013 | CN101072758B 喹唑啉衍生物 Quinazoline derivatives |
| 07/30/2013 | US8497368 Heterocyclic hydrazone compounds |
| 07/30/2013 | US8497352 Use of Wnt5-α peptide derivates for the treatment of melanoma and gastric cancer |
| 07/30/2013 | US8497351 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer |
| 07/30/2013 | US8497349 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation |
| 07/30/2013 | US8497283 Autotaxin inhibitors |
| 07/30/2013 | US8497241 WNT10-derived peptide and use thereof |
| 07/30/2013 | US8496965 Pellet formulation for the treatment of the intenstinal tract |
| 07/30/2013 | CA2714700C Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 07/30/2013 | CA2691091C Fusion protein, macromolecule assembled from the fusion protein, and its use in the prevention or treatment of human papillomavirus related diseases |
| 07/30/2013 | CA2678008C Methods of treating a secondary bone tumor with anti-pdgfralpha antibodies |
| 07/30/2013 | CA2659549C Compositions and methods relating to novel compounds and targets thereof |
| 07/30/2013 | CA2599611C Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer |
| 07/30/2013 | CA2599538C N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 07/30/2013 | CA2540138C Recombinant antibody against human insulin-like growth factor |
| 07/30/2013 | CA2531856C Benzimidazole carboxamides as raf kinase inhibitors |
| 07/30/2013 | CA2523517C Bcl2l12 polypeptide activators and inhibitors |
| 07/30/2013 | CA2518944C Inhibitors of extracellular hsp90 |
| 07/30/2013 | CA2515335C Growth factor complexes and modulation of cell migration and growth |
| 07/30/2013 | CA2479764C Hemiasterlin derivatives and uses thereof |
| 07/30/2013 | CA2451874C Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 07/25/2013 | WO2013109998A1 Metalloenzyme inhibitor compounds |
| 07/25/2013 | WO2013109675A2 Compositions and methods for treating cancer and inflammation-related diseases and conditions |
| 07/25/2013 | WO2013109610A1 Pharmaceutical compositions and methods |
| 07/25/2013 | WO2013109142A1 Combined pdk and mapk/erk pathway inhibition in neoplasia |
| 07/25/2013 | WO2013108869A1 Therapeutic or prophylactic agent for cancer |
| 07/25/2013 | WO2013108809A1 3,5-disubstituted alkynylbenzene compound and salt thereof |
| 07/25/2013 | WO2013108754A1 Pyrazine carboxamide compound |
| 07/25/2013 | WO2013107883A1 Tetrahydrofolates in combination with egfr-inhibitors |
| 07/25/2013 | WO2013107882A1 Anti-tumor activity of reduced folates like methylene-tetrahydrofolate |
| 07/25/2013 | WO2013107839A2 Phospholipid compounds for use in skin cancer treatment |
| 07/25/2013 | WO2013107820A1 Novel fap inhibitors |
| 07/25/2013 | WO2013107429A1 1-oxo/acylation-14-acylated oridonin derivative, preparation method therefor and application thereof |